Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1966 2
1967 2
1968 3
1970 2
1971 1
1973 1
1974 4
1975 3
1976 7
1977 7
1978 10
1979 8
1980 8
1981 11
1982 14
1983 11
1984 25
1985 18
1986 18
1987 17
1988 13
1989 9
1990 13
1991 11
1992 14
1993 14
1994 30
1995 32
1996 36
1997 32
1998 21
1999 21
2000 35
2001 27
2002 23
2003 28
2004 28
2005 23
2006 24
2007 33
2008 37
2009 57
2010 60
2011 61
2012 63
2013 62
2014 91
2015 65
2016 62
2017 71
2018 79
2019 95
2020 132
2021 149
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,575 results
Results by year
Filters applied: . Clear all
Page 1
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Goldman JD, et al. Among authors: galli m. N Engl J Med. 2020 Nov 5;383(19):1827-1837. doi: 10.1056/NEJMoa2015301. Epub 2020 May 27. N Engl J Med. 2020. PMID: 32459919 Free PMC article. Clinical Trial.
Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Antinori S, et al. Among authors: galli m. Eur J Intern Med. 2016 Oct;34:21-28. doi: 10.1016/j.ejim.2016.06.029. Epub 2016 Jul 7. Eur J Intern Med. 2016. PMID: 27394927 Review.
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
Solerte SB, Di Sabatino A, Galli M, Fiorina P. Solerte SB, et al. Among authors: galli m. Acta Diabetol. 2020 Jul;57(7):779-783. doi: 10.1007/s00592-020-01539-z. Epub 2020 Jun 6. Acta Diabetol. 2020. PMID: 32506195 Free PMC article. Review.
Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.
Zehender G, Lai A, Bergna A, Meroni L, Riva A, Balotta C, Tarkowski M, Gabrieli A, Bernacchia D, Rusconi S, Rizzardini G, Antinori S, Galli M. Zehender G, et al. Among authors: galli m. J Med Virol. 2020 Sep;92(9):1637-1640. doi: 10.1002/jmv.25794. Epub 2020 Apr 10. J Med Virol. 2020. PMID: 32222993 Free PMC article.
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
Tortorici MA, Beltramello M, Lempp FA, Pinto D, Dang HV, Rosen LE, McCallum M, Bowen J, Minola A, Jaconi S, Zatta F, De Marco A, Guarino B, Bianchi S, Lauron EJ, Tucker H, Zhou J, Peter A, Havenar-Daughton C, Wojcechowskyj JA, Case JB, Chen RE, Kaiser H, Montiel-Ruiz M, Meury M, Czudnochowski N, Spreafico R, Dillen J, Ng C, Sprugasci N, Culap K, Benigni F, Abdelnabi R, Foo SC, Schmid MA, Cameroni E, Riva A, Gabrieli A, Galli M, Pizzuto MS, Neyts J, Diamond MS, Virgin HW, Snell G, Corti D, Fink K, Veesler D. Tortorici MA, et al. Among authors: galli m. Science. 2020 Nov 20;370(6519):950-957. doi: 10.1126/science.abe3354. Epub 2020 Sep 24. Science. 2020. PMID: 32972994 Free PMC article.
Cistrome and Epicistrome Features Shape the Regulatory DNA Landscape.
O'Malley RC, Huang SC, Song L, Lewsey MG, Bartlett A, Nery JR, Galli M, Gallavotti A, Ecker JR. O'Malley RC, et al. Among authors: galli m. Cell. 2016 May 19;165(5):1280-1292. doi: 10.1016/j.cell.2016.04.038. Cell. 2016. PMID: 27203113 Free PMC article.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Among authors: galli m. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Riva A, Barcella V, Benatti SV, Capobianco M, Capra R, Cinque P, Comi G, Fasolo MM, Franzetti F, Galli M, Gerevini S, Meroni L, Origoni M, Prosperini L, Puoti M, Scarpazza C, Tortorella C, Zaffaroni M, Moiola L. Riva A, et al. Among authors: galli m. Mult Scler. 2021 Mar;27(3):347-359. doi: 10.1177/1352458520952310. Epub 2020 Sep 17. Mult Scler. 2021. PMID: 32940128 Review.
1,575 results